Friday, June 19, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 897 of 1,261

  1. US 8318182

    Vault compositions for immunization against Chlamydia genital infection

    The Regents of the University of California · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  2. US 8318467

    Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

    Vertex Pharmaceuticals Incorporated · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  3. US 8318145

    Multi-arm polymer prodrugs

    Nektar Therapeutics · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  4. US 8318154

    Super fast-acting insulin compositions

    HALOZYME, INC. · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  5. US 8318183

    Plasmodium liver stage antigens

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  6. US 8318722

    Pyrazinooxazepine derivatives

    Takeda Pharmaceutical Company Limited · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  7. US 8318727

    Polo-like kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  8. US 8318483

    Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

    Advanced Technologies and Regenerative Medicine, LLC · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  9. US 8318425

    Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

    The United States of America, as Represented by the Secretary, Department of Human Services · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  10. US 8318765

    3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  11. US 8318906

    EMP2 antibodies and their therapeutic uses

    The Regents of the University of California · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  12. US 8318951

    Stem cell differentiating agents and uses therefor

    The Board of Regents of the University of Texas System · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  13. US 8318939

    Kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  14. US 8318945

    Metalloprotein inhibitors

    The Regents of the University of California · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  15. US 8318693

    Compositions and methods for inhibiting expression of mutant EGFR gene

    Alnylam Pharmaceuticals, Inc. · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  16. US 8318490

    Prelamin A pre peptide as a universal stem cell differentiation signal

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  17. US 8318666

    Use of leptin to treat metabolic abnormalities associated with lipoatrophy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  18. US 8318700

    Lung-targeted drugs

    The Regents of the University of California · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  19. US 8318817

    Controlled release antimicrobial compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  20. US 8318746

    Nitrogen-containing five-membered heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  21. US 8318733

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  22. US 8314239

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted

  23. US 8314217

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted

  24. US 8314125

    Bicyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.